Atlas Trials

Cytomegalovirus (CMV) Perilymphatic Fluid

Clinical trial NCT04724265 · UNKNOWN

Trial details

NCT number
NCT04724265
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hearing Loss, CochlearCytomegalovirus Congenital
Start date
2020-12-10
Primary completion
2022-12-10
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.